ES2072334T3 - Derivados de 4,5,5a,6-tetrahidro-3h-isoxazolo(5,4,3-kl)acridinas, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

Derivados de 4,5,5a,6-tetrahidro-3h-isoxazolo(5,4,3-kl)acridinas, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
ES2072334T3
ES2072334T3 ES90110684T ES90110684T ES2072334T3 ES 2072334 T3 ES2072334 T3 ES 2072334T3 ES 90110684 T ES90110684 T ES 90110684T ES 90110684 T ES90110684 T ES 90110684T ES 2072334 T3 ES2072334 T3 ES 2072334T3
Authority
ES
Spain
Prior art keywords
chem
loweralkyl
isoxazolo
acridines
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90110684T
Other languages
English (en)
Inventor
Gregory Michael Shutske
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2072334T3 publication Critical patent/ES2072334T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Liquid Crystal Substances (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE PRESENTAN COMPUESTOS DE FORMULA (I), DONDE: X ES HIDROGENO, ALQUIL INFERIOR, HALOGENO O TRIFLUOMETIL, Y R, CUANDO ESTA PRESENTE, ES UN HIDROGENO, ALQUIL INFERIOR, ALLIL, (II) DONDE R1 ES ALQUIL INFERIOR, -CH2C=CH, (III), (IV) O (V), SIENDO N 2, 3 O 4 Y R2 Y R3 SIENDO INDEPENDIENTEMENTE, ALQUIL INFERIOR, O EL GRUPO -N R2 R3, TOMADOS COMO EL CONSTITUYENTE TOTAL (IV), CUYOS COMPUESTOS SE UTILIZAN COMO AGENTES ANALGESICOS Y TAMBIEN PARA EL TRATAMIENTO DE VARIAS DISFUNCIONES DE LA MEMORIA, CARACTERIZADAS POR UN DESCENSO DE LA FUNCION COLINERGICA, TAL COMO EN LA ENFERMEDAD DE ALZAHEIMER.
ES90110684T 1989-06-09 1990-06-06 Derivados de 4,5,5a,6-tetrahidro-3h-isoxazolo(5,4,3-kl)acridinas, un procedimiento para su preparacion y su uso como medicamentos. Expired - Lifetime ES2072334T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/364,420 US4920117A (en) 1989-06-09 1989-06-09 4,5,5a,6-tetrahydro-3H-isoxazolo(5,4,3-kl)acridines, pharmaceutical compositions and use

Publications (1)

Publication Number Publication Date
ES2072334T3 true ES2072334T3 (es) 1995-07-16

Family

ID=23434459

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90110684T Expired - Lifetime ES2072334T3 (es) 1989-06-09 1990-06-06 Derivados de 4,5,5a,6-tetrahidro-3h-isoxazolo(5,4,3-kl)acridinas, un procedimiento para su preparacion y su uso como medicamentos.

Country Status (17)

Country Link
US (1) US4920117A (es)
EP (1) EP0401779B1 (es)
JP (1) JPH089624B2 (es)
KR (1) KR0148365B1 (es)
AT (1) ATE122047T1 (es)
AU (1) AU619985B2 (es)
CA (1) CA2018564C (es)
DE (1) DE69019066T2 (es)
DK (1) DK0401779T3 (es)
ES (1) ES2072334T3 (es)
FI (1) FI902851A0 (es)
IE (1) IE67074B1 (es)
IL (1) IL94664A (es)
NO (1) NO902556L (es)
NZ (1) NZ233971A (es)
PT (1) PT94298B (es)
ZA (1) ZA904442B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927820A (en) * 1988-11-25 1990-05-22 Hoechst Roussel Pharmaceuticals Inc. Fused heterocyclic derivatives of 1,2,3,4-tetrahydroacridine
US5236930A (en) * 1989-11-13 1993-08-17 Mitbushi Gas Chemical Company, Inc. Oxazopyrroloquinolines and use of oxazopyrroloquinolines
EP1484325B1 (en) 2002-03-08 2014-06-18 Japan Science and Technology Agency Isoxazole derivatives and process for producing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8314391D0 (en) * 1983-05-24 1983-06-29 Kefalas As Heterocyclic compounds
FR2566407B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant
US4927820A (en) * 1988-11-25 1990-05-22 Hoechst Roussel Pharmaceuticals Inc. Fused heterocyclic derivatives of 1,2,3,4-tetrahydroacridine

Also Published As

Publication number Publication date
NZ233971A (en) 1992-11-25
ZA904442B (en) 1991-03-27
JPH089624B2 (ja) 1996-01-31
IE902078L (en) 1990-12-09
JPH0324085A (ja) 1991-02-01
IE67074B1 (en) 1996-02-21
EP0401779A1 (en) 1990-12-12
KR0148365B1 (ko) 1998-11-02
KR910000744A (ko) 1991-01-30
PT94298B (pt) 1997-01-31
DE69019066T2 (de) 1995-10-19
NO902556D0 (no) 1990-06-08
CA2018564A1 (en) 1990-12-09
US4920117A (en) 1990-04-24
EP0401779B1 (en) 1995-05-03
ATE122047T1 (de) 1995-05-15
DK0401779T3 (da) 1995-10-16
IL94664A (en) 1994-11-11
PT94298A (pt) 1991-02-08
AU619985B2 (en) 1992-02-06
CA2018564C (en) 2002-11-12
DE69019066D1 (de) 1995-06-08
AU5691790A (en) 1990-12-13
NO902556L (no) 1990-12-10
FI902851A0 (fi) 1990-06-07
IL94664A0 (en) 1991-04-15

Similar Documents

Publication Publication Date Title
FI873631A (fi) --alkyl-4-amino-3-kinolinmetanoler och 1-(4-aralkylamino-3-kinolinyl)alkanoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DK0420140T3 (da) N-Aminocarbamater beslægtede med physostigmin, en fremgangsmåde til deres fremstilling og deres anvedelse som lægemidler
ES2121761T3 (es) Carbamatos sustituidos de 1-(piridinilamino sustituido)-1h-indol-5-ilo, un procedimiento para su preparacion y su uso como medicamentos.
FI875145A0 (fi) Kondenserade heterocykliska tetrahydroaminokinoliner och beslaektade foereningar, en metod foer deras framstaellning och deras anvaendning som mediciner.
FI895288A0 (fi) 1,2,3,4-tetrahydro-1,9-akridinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ES2064533T3 (es) Acido(1,2,3,4-tetrahidro-9-acridinimino)-ciclohexanocarboxilico y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
ES2072334T3 (es) Derivados de 4,5,5a,6-tetrahidro-3h-isoxazolo(5,4,3-kl)acridinas, un procedimiento para su preparacion y su uso como medicamentos.
MX25922A (es) Pirido (3,4-b) pirrolo (1,2-e)(1,4,5)oxadiazepinasy compuestos analogos relacionados un procedimiento para su preparacion y su uso como medicamentos
DE68914600D1 (de) Kondensierte heterocyclische Derivate von 1,2,3,4-Tetrahydroacridin, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 401779

Country of ref document: ES